Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Kindred Biosciences, Inc. | exhibit321-202010k.htm |
| EX-31.2 - EX-31.2 - Kindred Biosciences, Inc. | exhibit312-202010k.htm |
| EX-31.1 - EX-31.1 - Kindred Biosciences, Inc. | exhibit311-202010k.htm |
| EX-21.1 - EX-21.1 - Kindred Biosciences, Inc. | exhibit211-202010k.htm |
| EX-10.30 - EX-10.30 - Kindred Biosciences, Inc. | exhibit1030-firstamendment.htm |
| EX-10.29 - EX-10.29 - Kindred Biosciences, Inc. | exhibit1029-elancoletterag.htm |
| EX-10.26 - EX-10.26 - Kindred Biosciences, Inc. | exhibit1026-secondamendmen.htm |
| EX-10.12 - EX-10.12 - Kindred Biosciences, Inc. | exhibit1012fourthleaseadde.htm |
| EX-4.4 - EX-4.4 - Kindred Biosciences, Inc. | exhibit44-202010k.htm |
| 10-K - 10-K - Kindred Biosciences, Inc. | kin-20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement Nos. 333-193039, 333-200687, 333-211839, 333-226321 and 333-240083 on Form S-8 and Registration Statement No. 333-252173 on Form S-3 of our reports dated March 16, 2021, relating to the consolidated financial statements of Kindred Biosciences, Inc. and subsidiaries appearing in this Annual Report on Form 10-K of Kindred Biosciences, Inc. for the year ended December 31, 2020.
/s/ KMJ Corbin & Company LLP
Costa Mesa, California
March 16, 2021